These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34217654)

  • 1. Applicability of the AHA/ACC/HRS Guideline for Implantable Cardioverter Defibrillator Implantation in Japanese Patients With Cardiac Sarcoidosis.
    Takenaka S; Kobayashi Y; Nagai T; Kato Y; Komoriyama H; Nagano N; Kamiya K; Konishi T; Sato T; Omote K; Mizuguchi Y; Tada A; Sato T; Iwano H; Kusano K; Ishibashi-Ueda H; Anzai T
    JACC Clin Electrophysiol; 2021 Nov; 7(11):1410-1418. PubMed ID: 34217654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis.
    Kazmirczak F; Chen KA; Adabag S; von Wald L; Roukoz H; Benditt DG; Okasha O; Farzaneh-Far A; Markowitz J; Nijjar PS; Velangi PS; Bhargava M; Perlman D; Duval S; Akçakaya M; Shenoy C
    Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007488. PubMed ID: 31431050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator.
    Nordenswan HK; Pöyhönen P; Lehtonen J; Ekström K; Uusitalo V; Niemelä M; Vihinen T; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Alatalo A; Pietilä-Effati P; Kupari M
    Circulation; 2022 Sep; 146(13):964-975. PubMed ID: 36000392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Kusumoto FM; Bailey KR; Chaouki AS; Deshmukh AJ; Gautam S; Kim RJ; Kramer DB; Lambrakos LK; Nasser NH; Sorajja D
    J Am Coll Cardiol; 2018 Oct; 72(14):1653-1676. PubMed ID: 29097297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ICDs in patients with sarcoidosis-A comprehensive review.
    Mactaggart S; Ahmed R
    Curr Probl Cardiol; 2024 May; 49(5):102483. PubMed ID: 38401822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Kusumoto FM; Bailey KR; Chaouki AS; Deshmukh AJ; Gautam S; Kim RJ; Kramer DB; Lambrakos LK; Nasser NH; Sorajja D
    Heart Rhythm; 2018 Oct; 15(10):e253-e274. PubMed ID: 29097318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Kusumoto FM; Bailey KR; Chaouki AS; Deshmukh AJ; Gautam S; Kim RJ; Kramer DB; Lambrakos LK; Nasser NH; Sorajja D
    Circulation; 2018 Sep; 138(13):e392-e414. PubMed ID: 29084732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator.
    Mohsen A; Jimenez A; Hood RE; Dickfeld T; Saliaris A; Shorofsky S; Saba MM
    J Cardiovasc Electrophysiol; 2014 Feb; 25(2):171-6. PubMed ID: 24433308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of appropriate implantable cardiac defibrillator therapy in cardiac sarcoidosis.
    Mathijssen H; Bakker ALM; Balt JC; Akdim F; van Es HW; Veltkamp M; Grutters JC; Post MC
    J Cardiovasc Electrophysiol; 2022 Jun; 33(6):1272-1280. PubMed ID: 35411644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting therapies in Japanese hypertrophic cardiomyopathy patients with an implantable cardioverter-defibrillator using the 2014 European Society of Cardiology guidelines.
    Nakano M; Kondo Y; Nakano M; Kajiyama T; Miyazawa K; Hayashi T; Ito R; Takahira H; Kobayashi Y
    Heart Vessels; 2021 Jan; 36(1):99-104. PubMed ID: 32666207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Maron MS; Rowin EJ; Wessler BS; Mooney PJ; Fatima A; Patel P; Koethe BC; Romashko M; Link MS; Maron BJ
    JAMA Cardiol; 2019 Jul; 4(7):644-657. PubMed ID: 31116360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.
    Betensky BP; Tschabrunn CM; Zado ES; Goldberg LR; Marchlinski FE; Garcia FC; Cooper JM
    Heart Rhythm; 2012 Jun; 9(6):884-91. PubMed ID: 22338670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS).
    ; Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Bergen NHV; Wackel PL
    JACC Clin Electrophysiol; 2021 Nov; 7(11):1437-1472. PubMed ID: 34794667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].
    Daniłowicz-Szymanowicz L; Szwoch M; Raczak J; Raczak G
    Pol Merkur Lekarski; 2012 Oct; 33(196):193-7. PubMed ID: 23272605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
    Wang J; Yang S; Ma X; Zhao K; Yang K; Yu S; Yin G; Dong Z; Song Y; Cui C; Li J; Wang C; Hao J; Lu M; Chen X; Zhao S
    Eur Heart J; 2023 Dec; 44(45):4781-4792. PubMed ID: 37795986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy.
    Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L
    Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
    Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
    Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis and Outcomes of Clinically Diagnosed Cardiac Sarcoidosis Without Positive Endomyocardial Biopsy Findings.
    Kusano K; Ishibashi K; Noda T; Nakajima K; Nakasuka K; Terasaki S; Hattori Y; Nagayama T; Mori K; Takaya Y; Miyamoto K; Nagase S; Aiba T; Yasuda S; Kitakaze M; Kamakura S; Yazaki Y; Morimoto SI; Isobe M; Terasaki F
    JACC Asia; 2021 Dec; 1(3):385-395. PubMed ID: 36341209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE-CMR.
    van der Lingen ACJ; Becker MAJ; Kemme MJB; Rijnierse MT; Spoormans EM; Timmer SAJ; van Rossum AC; van Halm VP; Germans T; Allaart CP
    J Am Heart Assoc; 2021 Apr; 10(8):e019101. PubMed ID: 33821672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.